Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature.
Saved in:
| Title: | Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature. |
|---|---|
| Authors: | Bloomer CH; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Gavrila E; Wake Forest University School of Medicine, Winston-Salem, NC, USA., Burcher KM; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Kalada JM; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Chang MJ; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Gebeyehu RR; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Asare E; Department of Internal Medicine, Jefferson Methodist Hospital, Philadelphia, PA, USA., Khoury LM; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Kinney R; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA., Frizzell B; Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Sullivan CA; Department of Otolaryngology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Bunch PM; Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Porosnicu M; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2023 Aug 31; Vol. 15, pp. 17588359231193722. Date of Electronic Publication: 2023 Aug 31 (Print Publication: 2023). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37667781 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bloomer+CH%22">Bloomer CH</searchLink>; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Gavrila+E%22">Gavrila E</searchLink>; Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Burcher+KM%22">Burcher KM</searchLink>; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Kalada+JM%22">Kalada JM</searchLink>; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Chang+MJ%22">Chang MJ</searchLink>; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Gebeyehu+RR%22">Gebeyehu RR</searchLink>; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Asare+E%22">Asare E</searchLink>; Department of Internal Medicine, Jefferson Methodist Hospital, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Khoury+LM%22">Khoury LM</searchLink>; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Kinney+R%22">Kinney R</searchLink>; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Frizzell+B%22">Frizzell B</searchLink>; Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Sullivan+CA%22">Sullivan CA</searchLink>; Department of Otolaryngology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Bunch+PM%22">Bunch PM</searchLink>; Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Porosnicu+M%22">Porosnicu M</searchLink>; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101510808%22">Therapeutic advances in medical oncology</searchLink> [Ther Adv Med Oncol] 2023 Aug 31; Vol. 15, pp. 17588359231193722. <i>Date of Electronic Publication: </i>2023 Aug 31 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Case Reports; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101510808 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1758-8340 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217588340%22">17588340 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Med Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37667781 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/17588359231193722 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 17588359231193722 Titles: – TitleFull: Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bloomer CH – PersonEntity: Name: NameFull: Gavrila E – PersonEntity: Name: NameFull: Burcher KM – PersonEntity: Name: NameFull: Kalada JM – PersonEntity: Name: NameFull: Chang MJ – PersonEntity: Name: NameFull: Gebeyehu RR – PersonEntity: Name: NameFull: Asare E – PersonEntity: Name: NameFull: Khoury LM – PersonEntity: Name: NameFull: Kinney R – PersonEntity: Name: NameFull: Frizzell B – PersonEntity: Name: NameFull: Sullivan CA – PersonEntity: Name: NameFull: Bunch PM – PersonEntity: Name: NameFull: Porosnicu M IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 08 Text: 2023 Aug 31 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 1758-8340 Numbering: – Type: volume Value: 15 Titles: – TitleFull: Therapeutic advances in medical oncology Type: main |
| ResultId | 1 |